Photocure ASA Photocure ORD SH

E:0IMT 
(LSE_INTL) 
 
nok 29,50
Opdateret 14-03-2018
Ændring % 0,00% Aktiekurs uændret
Ændring 0,00 Aktiekurs uændret
Volume 0
Høj NOK 0
Lav NOK 0
Åben NOK 0
ISIN NO0010000045
Seneste luk NOK 24,30
# af aktier 21,56M
Markedsværdi 635,96M NOK
I dag

Photocure ASA Photocure ORD SH
Markedet er åbent (indtil 18:15) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  29,50 4,1% Stigning i aktiekurs 4,1% Stigning i aktiekurs 9,9% Stigning i aktiekurs 33,3% Stigning i aktiekurs -22,2% Fald i aktiekurs
Powered by TradingView

Nyheder om Photocure ASA Photocure ORD SH

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser

Firmaprofil

PhotoCure ASA is a Norway based specialty pharmaceutical company. Its technology platform is focused on the field of photodynamic diagnosis and treatment in the areas of dermatology and cancer. The group has operations in Norway, Sweden, Denmark, Finland and the United States. The operating segments of the group are Commercial franchise and Development portfolio. The company markets product through its commercial operation in the Nordic region under the brand name Hexvix and in the US under the brand name Cysview. It generates prime revenue from the Commercial franchise segment which includes the Hexvix and Cysview products. In addition, the firm also has two device products, Cevira and Visonac, both targeted at indications with medical need and market potential.

Copyright Euroinvestor A/S 2018  Disclaimer Cookie- og privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. april 2018 15:38:27
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180423.5 - EUROWEB1 - 2018-04-23 15:38:27 - 2018-04-23 15:38:27 - 1 - Website: OKAY